TY - JOUR
T1 - Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by helicobacter pylori lipopolysaccharide
AU - Slomiany, A.
AU - Piotrowski, J.
AU - Slomiany, B. L.
PY - 1995
Y1 - 1995
N2 - Background: Among the disturbances in gastric mucosal defense associated with Helicobacter pylori infection is the loss of mucus coat continuity, which results in a severe disturbance in the ability of mucus coat to maintain its functions as the pre-epithelial element of gastric mucosal defense. Here, we show that H. pylori, through its cell-wall lipopolysaccharide, disrupts the interaction between gastric mucin and its mucosal receptor, and that sucralfate is capable of counteracting this untoward effect of the bacterium. Methods: The receptor was isolated from octylglucoside-solubilized gastric mucosal epithelial cell membranes by affinity chromatography on Sepharose-bound wheat germ agglutinin and following iodination with 125I, used in the binding assays for mucin in the presence of H. pylori lipopolysaccharide and sucralfate. Results: Preincubation of the receptor protein with H. pylori lipopolysaccharide led to a decrease in mucin binding. The inhibitory effect was proportional to the concentration of lipopolysaccharide and reached a maximum of 91% at 30 μg/ml. The effect of H. pylori lipopolysaccharide was countered by sucralfate, which caused a dose-dependent relief of the inhibitory effect. The maximum (75% restoration in mucin-receptor binding occurred at 60 μg/ml sucralfate. Conclusions: The results provide strong evidence for the effectiveness of sucralfate in preventing the loss of gastric mucus coat continuity caused by H. pylori.
AB - Background: Among the disturbances in gastric mucosal defense associated with Helicobacter pylori infection is the loss of mucus coat continuity, which results in a severe disturbance in the ability of mucus coat to maintain its functions as the pre-epithelial element of gastric mucosal defense. Here, we show that H. pylori, through its cell-wall lipopolysaccharide, disrupts the interaction between gastric mucin and its mucosal receptor, and that sucralfate is capable of counteracting this untoward effect of the bacterium. Methods: The receptor was isolated from octylglucoside-solubilized gastric mucosal epithelial cell membranes by affinity chromatography on Sepharose-bound wheat germ agglutinin and following iodination with 125I, used in the binding assays for mucin in the presence of H. pylori lipopolysaccharide and sucralfate. Results: Preincubation of the receptor protein with H. pylori lipopolysaccharide led to a decrease in mucin binding. The inhibitory effect was proportional to the concentration of lipopolysaccharide and reached a maximum of 91% at 30 μg/ml. The effect of H. pylori lipopolysaccharide was countered by sucralfate, which caused a dose-dependent relief of the inhibitory effect. The maximum (75% restoration in mucin-receptor binding occurred at 60 μg/ml sucralfate. Conclusions: The results provide strong evidence for the effectiveness of sucralfate in preventing the loss of gastric mucus coat continuity caused by H. pylori.
KW - Antimicrobial agents
KW - Effect of sucralfate
KW - Helicobacter pylori
KW - Susceptibility
UR - http://www.scopus.com/inward/record.url?scp=0028863164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028863164&partnerID=8YFLogxK
U2 - 10.3109/00365529509090277
DO - 10.3109/00365529509090277
M3 - Article
C2 - 8578214
AN - SCOPUS:0028863164
SN - 0036-5521
VL - 30
SP - 77
EP - 81
JO - Scandinavian Journal of Gastroenterology
JF - Scandinavian Journal of Gastroenterology
IS - S210
ER -